<?xml version="1.0" encoding="UTF-8"?>
<p>The efficacy and safety of 
 <italic>Andrographis</italic>‐containing preparations were studied in patients with common cold in Scandinavia, South America, and India.
 <xref rid="med21743-bib-0406" ref-type="ref">
  <sup>406</sup>
 </xref>, 
 <xref rid="med21743-bib-0407" ref-type="ref">
  <sup>407</sup>
 </xref>, 
 <xref rid="med21743-bib-0408" ref-type="ref">
  <sup>408</sup>
 </xref>, 
 <xref rid="med21743-bib-0409" ref-type="ref">
  <sup>409</sup>
 </xref>, 
 <xref rid="med21743-bib-0410" ref-type="ref">
  <sup>410</sup>
 </xref>, 
 <xref rid="med21743-bib-0411" ref-type="ref">
  <sup>411</sup>
 </xref> Evidence from a meta‐analysis of the results of 33 RCTs showed that 
 <italic>Andrographis</italic> relieves inflammatory symptoms and shortens the duration of cough, sore throat, and sick leave/time to resolution when compared with usual care.
 <xref rid="med21743-bib-0411" ref-type="ref">
  <sup>411</sup>
 </xref>
</p>
